$1.31 Billion is the total value of BRIDGER MANAGEMENT, LLC's 39 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CZR | Sell | CAESARS ENTERTAINMENT INC NE | $82,455,000 | +8.6% | 1,110,206 | -18.0% | 6.29% | +3.6% |
| GDDY | Sell | GODADDY INCcl a | $78,816,000 | +7.4% | 950,160 | -1.7% | 6.01% | +2.4% |
| NTRA | Sell | NATERA INC | $70,067,000 | -26.3% | 704,050 | -46.5% | 5.34% | -29.7% |
| CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $54,457,000 | +2.2% | 82,317 | -3.6% | 4.15% | -2.5% |
| ALC | Sell | ALCON AG | $54,267,000 | -4.5% | 822,471 | -17.6% | 4.14% | -8.9% |
| MS | Sell | MORGAN STANLEY | $44,786,000 | +13.4% | 653,530 | -20.0% | 3.42% | +8.1% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $40,763,000 | -22.1% | 313,632 | -12.7% | 3.11% | -25.7% |
| LKQ | Sell | LKQ CORP | $39,651,000 | +12.0% | 1,125,180 | -11.9% | 3.02% | +6.8% |
| HCA | Sell | HCA HEALTHCARE INC | $35,927,000 | -19.5% | 218,454 | -39.0% | 2.74% | -23.2% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $29,931,000 | +46.0% | 1,524,760 | -3.6% | 2.28% | +39.2% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $28,099,000 | +12.6% | 2,466,972 | -11.1% | 2.14% | +7.4% |
| DXCM | Sell | DEXCOM INC | $9,659,000 | -25.1% | 26,124 | -16.5% | 0.74% | -28.5% |
| QTRX | Sell | QUANTERIX CORP | $6,309,000 | -10.2% | 135,685 | -34.8% | 0.48% | -14.4% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $6,239,000 | -61.2% | 30,650 | -64.1% | 0.48% | -63.0% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $5,283,000 | -80.5% | 68,764 | -81.0% | 0.40% | -81.4% |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -503,012 | -100.0% | -0.72% | – |
| BMYRT | Exit | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $0 | – | -4,427,269 | -100.0% | -0.80% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -105,411 | -100.0% | -1.09% | – |
| MGM | Exit | MGM RESORTS INTERNATIONAL | $0 | – | -957,528 | -100.0% | -1.66% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -799,880 | -100.0% | -3.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.